EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2023


Werte in diesem Artikel
Aktien

169.25 EUR -2.25 EUR -1.31 %

Disclosure of Share Capital and Voting Rights Outstanding
as of November 30, 2023

Werbung

(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Charenton-le-Pont, France (December 20, 2023 - 6:00 pm) – As of November 30, 2023, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below.

 November 30, 2023
Shares outstanding453,623,9551
Number of real voting rights (excluding treasury shares)451,333,896
Theoretical number of voting rights (including treasury shares)453,623,955

It is to be noted that voting rights are capped at 31%, applicable to any shareholder, in accordance with a formula contained in article 23 of EssilorLuxottica’s by-laws2.

Werbung

For further information, please consult the Prospectus which received Visa No. 18-460 from the AMF on September 28, 2018 and its Securities Note Supplement which received Visa No. 18-494 from the AMF on October 23, 2018, available on the website www.essilorluxottica.com.

1Including 11,490 shares delivered but not yet registered as of November 30, 2023.
2EssilorLuxottica’s by-laws are available on the Company’s website under the section Governance / Publications.

Attachment


Aktuelle EssilorLuxottica Aktie News

Werbung

EssilorLuxottica Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für EssilorLuxottica nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
14:36 EssilorLuxottica Overweight JP Morgan Chase & Co.
02.07.26 EssilorLuxottica Buy UBS AG
02.07.26 EssilorLuxottica Outperform RBC Capital Markets
30.06.26 EssilorLuxottica Overweight JP Morgan Chase & Co.
29.06.26 EssilorLuxottica Market-Perform Bernstein Research